| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See "remarks"
1 company
Conway Vikki L is a See "remarks" at TEVA. Recent filings cover 0 purchases and 5 sales.
Our model assigns Conway Vikki L a below-average insider score of 27/100, based on 4 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -15.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sell | 15,219 | $16.74 | $254,807.15 | -100% | +1.2% | +3.6% | |
| Mar 5, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE | 1,427 | $13.52 | $19,286.48 | -8.6% | +25.4% | +17.4% | |
| Mar 4, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE | 3,532 | $13.37 | $47,234.50 | -23.2% | +26.3% | +16.7% | |
| Feb 28, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE | 1,366 | $13.12 | $17,916.46 | -31.8% | +28.0% | +24.7% |